| Literature DB >> 35310797 |
Faiza Ahmed1, Lubna Abbasi2, Nida Ghouri3, Muhammad Junaid Patel4.
Abstract
Objectives: To determine epidemiology of in-hospital cardiac arrest (IHCA) in a tertiary care hospital, pre- and during pandemic.Entities:
Keywords: COVID-19; Causes of Cardiac arrest; Gender; In-hospital cardiac arrest
Year: 2022 PMID: 35310797 PMCID: PMC8899893 DOI: 10.12669/pjms.38.ICON-2022.5776
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Characteristics and outcomes of patients who experienced an IHCA in a tertiary-care hospital in Karachi Pakistan, 2019-2020.
| Variables | All | ROSC | p-value | Survival at Discharge | p-value |
|---|---|---|---|---|---|
|
|
| ||||
| n (%) | n(%) | ||||
| All IHCA patients, n (%) | 77 | 30 (39) | - | 28 (36.4) | - |
|
| |||||
| Male | 44 (57.1) | 15 (50) | 0.312[ | 14 (50) | NS |
| Female | 33 (42.9) | 15 (50) | 14 (50) | ||
|
| |||||
| Emergency department (ED) | 20 (26.0) | 17 (56.7) | 0.000[ | 17 (60.7) | 0.000[ |
| Intensive care unit (ICU) | 21 (27.3) | 4 (13.3) | 4 (14.3) | ||
| COVID ICU | 23 (29.9) | 3 (10) | 1 (3.6) | ||
| Other (ward, HDU, etc) | 13 (16.9) | 6 (20) | 6 (21.4) | ||
|
| |||||
| Shockable rhythm | |||||
| Ventricular fibrillation | 4 (5.2) | 2 (6.9) | NS | 2 (7.4) | NS |
| Pulseless ventricular tachycardia | 1 (1.3) | - | - | ||
| Non-shockable rhythm | |||||
| Pulseless electrical activity | 10 (13) | 1 (3.4) | 1 (3.7) | ||
| Asystole | 61 (79.2) | 26 (89.7) | 24 (88.9) | ||
|
| |||||
| Mild to no neurological disability | 51 (66.2) | 22 (75.9) | NS | 20 (74.1) | NS |
| Moderate disability | 7 (9.1) | 1 (3.4) | 1 (3.7) | ||
| Severe disability | 5 (6.5) | 2 (6.9) | 2 (7.4) | ||
| Coma or vegetative state | 12 (15.6) | 4 (13.8) | 4 (14.8) | ||
| Brain death | 1 (1.3) | 4 (13.8) | - | ||
|
| |||||
| Mechanical ventilation | 31 (44.9) | 4 (15.4) | 0.005[ | 3 (12) | 0.001[ |
| Renal insufficiency | 36 (52.2) | 11 (42.3) | 10 (40) | ||
| Hepatic insufficiency | 10 (14.5) | 4 (15.4) | 4 (16) | ||
| Sepsis | 34 (49.3) | 12 (46.2) | 12 (48.0) | ||
| Malignant disease | 2 (2.9) | - | - | ||
| Hypotension | 29 (42.0) | 9 (34.6) | 8 (32.0) | ||
p<0.05,
p<0.0001, NS not significant,
Chi square test,
Fisher exact test.
Fig.1Association of age and gender with IHCA.
Causes of patients who experienced an IHCA in pre pandemic and during pandemic.
| Variables, n (%) | Time of cardiac arrest | |||
|---|---|---|---|---|
| Pre-Pandemic (Aug ‘19 – Feb ’20) n=45 | Pandemic (Mar-Aug 2020) n=32 | Total n=77 | p-value | |
|
| 22 (48.9) | 8 (25) | 30 (39) | 0.034 |
|
| 22 (48.9) | 6 (18.8) | 28 (36.4) | 0.007[ |
|
| ||||
|
| ||||
| <30 year | 4 (16.7) | - | 4 (9.1) | NS |
| 30-39 year | 2 (8.3) | 3 (15) | 5 (11.4) | |
| 40-59 year | 11 (45.8) | 9 (45) | 20 (45.5) | |
| 60-69 year | 4 (16.7) | 3 (15) | 7 (15.9) | |
| 70 and above | 3 (12.5) | 5 (25) | 8 (18.2) | |
|
| ||||
| <30 year | 6 (28.6) | 4 (33.3) | 10 (30.3) | NS |
| 30-39 year | 3 (14.3) | 3 (25) | 6 (18.2) | |
| 40-59 year | 3 (14.3) | 4 (33.3) | 7 (21.2) | |
| 60-69 year | 6 (28.6) | 1 (8.3) | 7 (21.2) | |
| 70 and above | 3 (14.3) | - | 3 (9.1) | |
|
| ||||
|
| n=24 | n=20 | n=44 | |
| ROSC | 13 (54.2) | 2 (10) | 15 (34.1) | 0.002[ |
|
| n=21 | n=12 | n=33 | |
| ROSC | 9 (42.9) | 6 (50) | 15 (45.5) | NS |
|
| ||||
|
| n=24 | n=20 | n=44 | |
| Survived to discharge | 13 (54.2) | 1 (5) | 14 (31.8) | 0.000[ |
|
| n=21 | n=12 | n=33 | |
| Survived to discharge | 9 (42.9) | 5 (41.7) | 14 (42.4) | NS |
|
| ||||
| Shockable rhythm | ||||
| Ventricular fibrillation | 3 (3.8) | 1 (3.1) | 4 (5.3) | |
| Pulseless ventricular tachycardia | 1 (2.3) | - | 1 (1.3) | |
| Non-shockable rhythm | NS | |||
| Pulseless electrical activity | 8 (18.2) | 2 (6.3) | 10 (13.2) | |
| Asystole | 32 (72.7) | 29 (90.6) | 61 (80.3) | |
|
| ||||
| Cardiac | 16 (35.6) | 3 (9.4) | 19 (24.7) | 0.009[ |
| 4H4T | 39 (86.7) | 32 (100) | 71 (92.2) | 0.038[ |
| Sepsis | 23 (51.1) | 13 (40.6) | 36 (46.8) | NS |
|
| ||||
| Hypoxia | 20 (50) | 29 (90.6) | 49 (68.1) | 0.006[ |
| Hypovolemia | 1 (2.5) | - | 1 (1.4) | |
| Hypo/Hyperkalemia | 21(52.5) | 11 (34.4) | 32 (44.4) | |
| Thrombosis/pulmonary embolus | 2 (5) | 1 (3.1) | 3 (4.2) | |
| Toxication | 2 (5) | 2 (6.3) | 4 (5.6) | |
| Hydrogen ion (acidosis) | 25 (62.5) | 16 (50) | 41 (56.9) | |
p<0.05,
p<0.0001,
Chi square test,
Fisher exact test,
ɫ Independent sample t test